BRIEF-CSPC Pharmaceutical Announces A Product Licensing Agreement

April 18 (Reuters) - CSPC Pharmaceutical Group Ltd :

* UNIT ENTERED PRODUCT LICENSING AGREEMENT WITH GALAXY BIO, INC. FOR LICENSING & COMMERCIALIZATION OF "PACLITAXEL FOR INJECTION"

* GALAXY BIO TO PAY PRESCRIBED PCT OF NET PROFIT OF PRODUCT IN TERRITORY TO UNIT AS SALES ROYALTY DURING 20 YEAR TERM Source text for Eikon: Further company coverage:

Advertisement